Product Includes | Product # | Quantity | Mol. Wt | Isotype/Source |
---|---|---|---|---|
TBK1/NAK (E8I3G) Rabbit mAb | 38066 | 20 µl | 84 kDa | Rabbit IgG |
MAVS (D5A9E) Rabbit mAb | 24930 | 20 µl | 75, 52 kDa | Rabbit IgG |
TRAF2 (C192) Antibody | 4724 | 20 µl | 53 kDa | Rabbit  |
TRAF3 (E8H3B) Rabbit mAb | 33640 | 20 µl | 62 kDa | Rabbit IgG |
TRAF6 (E2K9D) Rabbit mAb | 67591 | 20 µl | 60 kDa | Rabbit IgG |
Phospho-TBK1/NAK (Ser172) (D52C2) XP® Rabbit mAb | 5483 | 20 µl | 84 kDa | Rabbit IgG |
IRF-3 (D6I4C) XP® Rabbit mAb | 11904 | 20 µl | 50-55 kDa | Rabbit IgG |
Phospho-IRF-3 (Ser386) (E7J8G) XP® Rabbit mAb | 37829 | 20 µl | 50-55 kDa | Rabbit IgG |
Phospho-IRF-3 (Ser396) (D6O1M) Rabbit mAb | 29047 | 20 µl | 45-55 kDa | Rabbit IgG |
Anti-rabbit IgG, HRP-linked Antibody | 7074 | 100 µl | Goat  |
Please visit cellsignal.com for individual component applications, species cross-reactivity, dilutions, protocols, and additional product information.
Description
The MAVS Signalosome Antibody Sampler Kit provides an economical means of detecting the activation of signaling pathways in which MAVS plays a critical role. The kit includes enough antibodies to perform two western blot experiments with each primary antibody.
Storage
Background
Recognition of conserved molecular structures of viruses by host pattern-recognition receptors (PRRs) initiates innate antiviral immune responses. Several families of PRRs have been demonstrated to sense different microbial components (1,2). The RIG-I-like receptor (RLR) family, including RIG-I, MDA5, and LGP2, are the primary PRRs to recognize viral RNAs (3,4). Upon binding to viral RNA, these receptors undergo conformation change, leading to their interaction with mitochondrial antiviral signaling protein (MAVS). MAVS subsequently forms large prion-like polymers and serves as a platform to recruit multiple components, including TRAF proteins and TBK1, to form the so-called MAVS signalosome. MAVS signalosome, in turn, activates the IRF-3 and NF-kB pathways, leading to the production of type I IFNs and pro-inflammatory cytokines (5-9).
- Akira, S. et al. (2006) Cell 124, 783-801.
- Kumar, H. et al. (2011) Int Rev Immunol 30, 16-34.
- Nakhaei, P. et al. (2009) Semin Immunol 21, 215-22.
- Yoneyama, M. et al. (2015) Curr Opin Immunol 32, 48-53.
- Seth, R.B. et al. (2005) Cell 122, 669-82.
- Vazquez, C. and Horner, S.M. (2015) J Virol 89, 6974-7.
- Reikine, S. et al. (2014) Front Immunol 5, 342.
- Dutta, S. et al. (2020) Front Microbiol 11, 1990.
- Thoresen, D. et al. (2021) Immunol Rev 304, 154-168.
Background References
Trademarks and Patents
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.